Effect of adipose tissue volume loss on circulating 25-hydroxyvitamin D levels: Results from a 1-year lifestyle intervention in viscerally obese men

International Journal of Obesity

Volumn 39, Issue 11, 2015, Pages 1638-1643

  Gangloff, A ^a,b   Bergeron, J ^b   Pelletier Beaumont, E ^a,c   Nazare, J A ^a,d   Smith, J ^a   Borel, A L ^a,e,f,g   Lemieux, I ^a   Tremblay, A ^a,c   Poirier, P ^a,h   Almeras N ^a,c   Despres J P ^a,c  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d CarMeN   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f University Grenoble Alpes   (France)

^g UNIV GRENOBLE ALPES   (France)

^h UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ABDOMINAL OBESITY; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY WEIGHT; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; EXERCISE; HUMAN; INTRAABDOMINAL FAT; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; CALORIC RESTRICTION; COMPLICATION; DYSLIPIDEMIAS; FEEDING BEHAVIOR; MEN'S HEALTH; MIDDLE AGED; OBESITY; QUEBEC; REFERENCE VALUE; RISK REDUCTION; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADIPOSITY; ADULT; BIOMARKERS; CALORIC RESTRICTION; DYSLIPIDEMIAS; EXERCISE; FOOD HABITS; HUMANS; MALE; MEN'S HEALTH; MIDDLE AGED; OBESITY; QUEBEC; REFERENCE VALUES; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME; VITAMIN D; WEIGHT LOSS;

EID: 84947027893     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.118     Document Type: Article

References (32)

1. International Association for the Study of Obesity. Obesity the global epidemic. Available at: http://www.iaso.org/iotf/obesity/obesitytheglobalepi demic/. Accessed 26 November 2013.
2. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87: 1080S-1086S.
3. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011; 31: 48-54.
4. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72: 690-693.
5. Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity. 2012; 20: 1444-1448.
6. Beckman LM, Earthman CP, Thomas W, Compher CW, Muniz J, Horst RL, et al. Serum 25(OH) vitamin D concentration changes after Roux-en-Y gastric bypass surgery. Obesity. 2013; 21: E599-E606.
7. Bell NH, Shaw S, Turner RT. Evidence that 1, 25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest. 1984; 74: 1540-1544.
8. Caron-Jobin M, Morisset AS, Tremblay A, Huot C, Légaré D, Tchernof A. Elevated serum 25(OH)D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women. Obesity. 2011; 19: 1335-1341.
9. Sulistyoningrum DC, Green TJ, Lear SA, De vlin AM. Ethnic-specific differences in vitamin d status is associated with adiposity. PLoS One. 2012; 7: e43159.
10. Borel AL, Nazare JA, Smith J, Alméras N, Tremblay A, Bergeron J, et al. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program. Obesity. 2012; 20: 1223-1233.
11. Borel AL, Nazare JA, Smith J, Alméras N, Tremblay A, Bergeron J, et al. Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity. Metabolism. 2012; 61: 262-272.
12. Pelletier-Beaumont E, Arsenault BJ, Alméras N, Bergeron J, Tremblay A, Poirier P, et al. Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men. Atherosclerosis. 2012; 221: 577-582.
13. Nazare JA, Smith J, Borel AL, Alméras N, Tremblay A, Bergeron J, et al. Changes in both global diet quality and physical activity level synergistically reduce visceral adiposity in men with features of metabolic syndrome. J Nutr. 2013; 143: 1074-1083.
14. Lohman GA, Roche AF, Martorell R (eds). Anthropometric Standardization Reference Manual. Human Kinetics Publishers: Champaign, IL, USA, 1988.
15. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord. 1993; 17: 187-196.
16. Després JP, Ross R, Boka G, Alméras N, Lemieux I. Effect of rimonabant on the hightriglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial. Arterioscler Thromb Vasc Biol. 2009; 29: 416-423.
17. Ferland M, De sprés JP, Tremblay A, Pinault S, Nadeau A, Moorjani S, et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr. 1989; 61: 139-148.
18. Paré A, Dumont M, Lemieux I, Brochu M, Alméras N, Lemieux S, et al. Is the relationship between adipose tissue and waist girth altered by weight loss in obese men?. Obes Res. 2001; 9: 526-534.
19. Agborsangaya C, Toriola AT, Grankvist K, Surcel HM, Holl K, Parkkila S, et al. The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione. Nutr Cancer. 2010; 62: 51-57.
20. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955; 34: 1345-1353.
21. Burstein M, Samaille J. Sur un dosage rapide du cholestérol lié aux b-lipoprotéines du sérum. Clin Chim Acta. 1960; 5: 609.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502.
23. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest. 1987; 47: 739-744.
24. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2010; 59: 242-248.
25. Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M, et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab. 2009; 94: 3306-3313.
26. Rock CL, Emond JA, Flatt SW, Heath DD, Karanja N, Pakiz B, et al. Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity. 2012; 20: 2296-2301.
27. Pramyothin P, Biancuzzo RM, Lu Z, Hess DT, Apovian CM, Holick MF. Vitamin D in adipose tissue and serum 25-hydroxyvitamin D after roux-en-Y gastric bypass. Obesity. 2011; 19: 2228-2234.
28. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007; 17: 319-326.
29. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444: 881-887.
30. Jacobs Jr DR, Steffen LM. Nutrients, foods, and dietary patterns as exposures in research: a framework for food synergy. Am J Clin Nutr. 2003; 78: 508S-513S.
31. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003; 77: 204-210.
32. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003; 88: 157-161.